Elite Pharmaceuticals, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Elite Pharmaceuticals, Inc. (ELTP) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $16.15 million as of 2021-03-31, per its 10-K filed 2021-06-14.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2021-06-14
- 2021-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $16.15M.
- 2020-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $10.66M.
- 2019-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$2.51M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2021-03-31 | $16.15M 10-K · filed 2021-06-14 |
| 2020-03-31 | $10.66M 10-K · filed 2021-06-14 |
| 2019-03-31 | -$2.51M 10-K · filed 2021-06-14 |